MAGNUSCONCORDIA (01172) subsidiary and Sichuan Juxinghua Trading separately entered into sale and purchase agreements for the purchase and sale of properties
MAGNUSCONCORDIA (01172) announced that on October 26, 2026, the seller, MAGNUSCONCORDIA Development (Chengdu) Co., Ltd. (an indirectly wholly-owned subsidiary of the Company), and the buyer, Sichuan Juxinghua Trading Co., Ltd., separately entered into sale and purchase agreements for the purchase and sale of the properties.
MAGNUSCONCORDIA (01172) announced that on October 26, 2026, the seller Rongtai Development (Chengdu) Co., Ltd. (an indirectly wholly-owned subsidiary of the Company) and the buyer Sichuan Juxinghua Trading Co., Ltd. separately entered into sale and purchase agreements for the purchase and sale of the property.
The subject property is an entire floor of commercial property located on the 6th floor of No. 1, Section 4, Renmin South Road, Wuhou District, Chengdu City, Sichuan Province, China.
The Directors believe that the disposal is a good opportunity for the Company to obtain funds to improve its cash flow position. The Directors believe that the terms of the sale and purchase agreements and the transactions contemplated thereunder are fair and reasonable and in the overall interests of the Company and its shareholders.
Related Articles

The Pacific Shipping (02343): Kristian Helt to step down as Executive Director

FUFENG GROUP (00546) repurchased 50,000 shares on October 26 for HK$199,500.

Morgan Stanley: SINOPHARM's (01099) Q3 results reflect that the domestic industry is still under pressure; maintains "Overweight" rating with a target price of HK$22.5
The Pacific Shipping (02343): Kristian Helt to step down as Executive Director

FUFENG GROUP (00546) repurchased 50,000 shares on October 26 for HK$199,500.

Morgan Stanley: SINOPHARM's (01099) Q3 results reflect that the domestic industry is still under pressure; maintains "Overweight" rating with a target price of HK$22.5






